Company Analysis

FibroBiologics, Inc. (FBLG)

Nasdaq: FBLG · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2023
Grade4.5
◀ Past 4.9● Present 2.9▶ Future 5.6
7 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

0 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to FibroBiologics, Inc.’s names, not what it holds today.

Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
7
3 of them in 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
FIBROBIOLOGICS, INC. its own name
named as the applicant on its applications, in US
0 granted
7 published
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 22, 20252025/0161367THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE REGENERATION AND REPAIR OF ATROPHIED SPLEENPharmaceuticalsFIBROBIOLOGICS, INC.
Mar 20, 20252025/0090717THERAPEUTIC USE OF FIBROBLASTS FOR ADHESIVE BANDAGE WOUND HEALINGMedical technologyFIBROBIOLOGICS, INC.
Mar 20, 20252025/0090594THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE THE IMMUNE SYSTEMPharmaceuticalsFIBROBIOLOGICS, INC.
Aug 8, 20242024/0263139REUSE OF FIBROBLASTS FOR SKIN AUGMENTATIONMedical technologyFIBROBIOLOGICS, INC.
Apr 11, 20242024/0115620PREPARATION AND THERAPEUTIC USE OF 3D-CULTURED FIBROBLASTSBiotechnologyFIBROBIOLOGICS, INC.
Sep 21, 20232023/0293595THERAPEUTIC USE OF FIBROBLASTS FOR USE IN WOUND HEALINGPharmaceuticalsFIBROBIOLOGICS, INC.
Nov 10, 20222022/0354898INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTSBiotechnologyFIBROBIOLOGICS, INC.
What it applied for, 2024 to 2025: Medical technology 2 · Pharmaceuticals 2 · Biotechnology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton FBLG · research, not advice